Health-related quality of life (HRQL) associated with bortezomib compared with high-dose dexamethasone in relapsed multiple myeloma (MM): Results from APEX study

Bortezomib is associated with better health-related quality of life than high-dose dexamethasone in patients with relapsed multiple myeloma: results from the APEX study

British Journal of Haematology ◽

10.1111/j.1365-2141.2008.07378.x ◽

2008 ◽

Cited By ~ 6

Author(s):

Stephanie J. Lee ◽

Paul G. Richardson ◽

Pieter Sonneveld ◽

Michael W. Schuster ◽

David Irwin ◽

...

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

High Dose ◽

Health Related Quality ◽

High Dose Dexamethasone ◽

Related Quality ◽

Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed and/or refractory multiple myeloma

Haematologica ◽

10.3324/haematol.2014.112557 ◽

2014 ◽

Vol 100 (2) ◽

pp. e63-e67 ◽

Cited By ~ 17

Author(s):

K. W. Song ◽

M. A. Dimopoulos ◽

K. C. Weisel ◽

P. Moreau ◽

A. Palumbo ◽

...

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

Low Dose ◽

High Dose ◽

Health Related Quality ◽

High Dose Dexamethasone ◽

Related Quality ◽

Faculty Opinions recommendation of Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969674.793470152 ◽

2013 ◽

Author(s):

Christopher Steer

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

Phase Iii ◽

Newly Diagnosed ◽

Health Related Quality ◽

Phase Iii Trial ◽

Related Quality ◽

Health‐related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial

British Journal of Haematology ◽

10.1111/bjh.17321 ◽

2021 ◽

Author(s):

Vania Hungria ◽

Meral Beksac ◽

Katja C. Weisel ◽

Ajay K. Nooka ◽

Tamas Masszi ◽

...

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

Phase Iii ◽

Health Related Quality ◽

Related Quality ◽

Health Related ◽

Over Time

Measurement of health‐related quality of life in multiple myeloma

British Journal of Haematology ◽

10.1046/j.1365-2141.1996.352889.x ◽

1996 ◽

Vol 92 (3) ◽

pp. 604-613 ◽

Cited By ~ 66

Author(s):

Finn Wisløff ◽

Sverre Eika ◽

Erik Hippe ◽

Martin Hjorth ◽

Erik Holmberg ◽

...

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

Health Related Quality ◽

Related Quality ◽

Changes of Terminal Cancer Patients' Health-related Quality of Life after High Dose Vitamin C Administration

Journal of Korean Medical Science ◽

10.3346/jkms.2007.22.1.7 ◽

2007 ◽

Vol 22 (1) ◽

pp. 7 ◽

Cited By ~ 67

Author(s):

Chang Hwan Yeom ◽

Gyou Chul Jung ◽

Keun Jeong Song

Keyword(s):

Quality Of Life ◽

Vitamin C ◽

Terminal Cancer ◽

High Dose ◽

Health Related Quality ◽

Terminal Cancer Patients ◽

Related Quality ◽

Health Related ◽

High Dose Vitamin

Health-related Quality of Life and Patients' Perceptions in Interferon-treated Multiple Myeloma Patients

Acta Oncologica ◽

10.1080/028418600750063550 ◽

2000 ◽

Vol 39 (7) ◽

pp. 809-813 ◽

Cited By ~ 12

Author(s):

Finn Wisløff, Nina Gulbrandsen

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

Health Related Quality ◽

Related Quality ◽

Impact of elotuzumab treatment on pain and health-related quality of life in patients with relapsed or refractory multiple myeloma: results from the ELOQUENT-2 study

Annals of Hematology ◽

10.1007/s00277-018-3469-4 ◽

2018 ◽

Vol 97 (12) ◽

pp. 2455-2463 ◽

Cited By ~ 7

Author(s):

David Cella ◽

Jan McKendrick ◽

Amber Kudlac ◽

Antonio Palumbo ◽

Abderrahim Oukessou ◽

...

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

Health Related Quality ◽

Related Quality ◽

Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma

Leukemia & Lymphoma ◽

10.1080/10428194.2020.1747066 ◽

2020 ◽

Vol 61 (8) ◽

pp. 1850-1859

Author(s):

Katja Weisel ◽

Meletios Dimopoulos ◽

Philippe Moreau ◽

Munci Yagci ◽

Alessandra Larocca ◽

...

Keyword(s):

Quality Of Life ◽

Multiple Myeloma ◽

Low Dose ◽

Health Related Quality ◽

Phase 3 ◽

Related Quality ◽

Health-related quality of life in outpatients with primary central nervous system lymphoma after radiotherapy and high-dose methotrexate chemotherapy

Molecular and Clinical Oncology ◽

10.3892/mco.2016.962 ◽

2016 ◽

Vol 5 (3) ◽

pp. 179-185 ◽

Cited By ~ 3

Author(s):

Yoshiko Okita ◽

Yoshitaka Narita ◽

Yasuji Miyakita ◽

Ruriko Miyahara ◽

Makoto Ohno ◽

...

Keyword(s):

Quality Of Life ◽

Central Nervous System Lymphoma ◽

High Dose ◽

High Dose Methotrexate ◽

Health Related Quality ◽

Dose Methotrexate ◽

Related Quality ◽

Health Related ◽

Methotrexate Chemotherapy